Health knowledge made personal
Join this community!
› Share page:
Search posts:

Medtronic Announces FDA Classification Of Deep Brain Stimulation Lead Cap Communication

Posted May 03 2013 9:16am
In keeping with its commitment to keep physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) issued an Urgent Medical Device Correction notification in February 2013 to provide physicians with information concerning the potential for deep brain stimulation (DBS) lead damage associated with the use of the lead cap provided in Medtronic DBS lead kits and dystonia therapy kits.
Post a comment
Write a comment:

Related Searches